Changes in left ventricular structure and function in Type 2 diabetic patients, depending on the presence of cardiac autonomic neuropathy and metabolic syndrome components

Aim. To assess the impact of cardiac autonomic neuropathy (CAP) on left ventricular (LV) structure and function in patients with Type 2 diabetes mellitus (DM-2), depending on the presence of metabolic syndrome (MS) components. Material and methods. The study included 157 patients (128 women and 29 m...

Full description

Saved in:
Bibliographic Details
Main Authors: E. Yu. Lunina, I. S. Petrukhin
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 1970-01-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/2067
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849342186619928576
author E. Yu. Lunina
I. S. Petrukhin
author_facet E. Yu. Lunina
I. S. Petrukhin
author_sort E. Yu. Lunina
collection DOAJ
description Aim. To assess the impact of cardiac autonomic neuropathy (CAP) on left ventricular (LV) structure and function in patients with Type 2 diabetes mellitus (DM-2), depending on the presence of metabolic syndrome (MS) components. Material and methods. The study included 157 patients (128 women and 29 men) with DM-2. MS was diagnosed according to WHO criteria. CAN was detected based on the standard Ewing test (≥2 positive results). M-mode, B-mode, and Doppler echocardiography was performed in 4 clinical groups: Group I (n=14): CAN-negative, ≤1 MS component; Group II (n=16): CAN-negative, ≥2 MS components; Group III (n=19): CAN-positive, ≤1 MS component; and Group IV (n=108): CAN-positive, ≥2 MS components. LV geometry type, as well as LV systolic and diastolic function, was assessed according to the standard criteria. Results. LV concentric hypertrophy (LVCH) was the most prevalent type of LV geometry in CAN-positive vs. CAN-negative patients (62,2% vs. 20,0%, respectively; p=0,02). The highest LVCH prevalence (63,9%) was registered in participants with CAN and ≥2 MS components. Over 50% of the patients with 0–1 MS component and two-thirds of the patients with ≥2 MS components had disturbed LV diastolic function. In the former, CAN presence did not affect the prevalence of diastolic dysfunction, while in the latter, diastolic dysfunction was significantly more prevalent among CAN-positive individuals (90,7%, compared to 56,2% in CAN-negative patients with ≥2 MS components; p=0,001). Conclusion. In DM-2 patients, CAN was associated with LVCH andLV diastolic dysfunction. This association strengthened, as the number of MS components increased.
format Article
id doaj-art-ff813bc1c5f344718105ead079d229ad
institution Kabale University
issn 1728-8800
2619-0125
language Russian
publishDate 1970-01-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj-art-ff813bc1c5f344718105ead079d229ad2025-08-20T03:43:29Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01251970-01-0110873781779Changes in left ventricular structure and function in Type 2 diabetic patients, depending on the presence of cardiac autonomic neuropathy and metabolic syndrome componentsE. Yu. Lunina0I. S. Petrukhin1Tver State Medical AcademyTver State Medical AcademyAim. To assess the impact of cardiac autonomic neuropathy (CAP) on left ventricular (LV) structure and function in patients with Type 2 diabetes mellitus (DM-2), depending on the presence of metabolic syndrome (MS) components. Material and methods. The study included 157 patients (128 women and 29 men) with DM-2. MS was diagnosed according to WHO criteria. CAN was detected based on the standard Ewing test (≥2 positive results). M-mode, B-mode, and Doppler echocardiography was performed in 4 clinical groups: Group I (n=14): CAN-negative, ≤1 MS component; Group II (n=16): CAN-negative, ≥2 MS components; Group III (n=19): CAN-positive, ≤1 MS component; and Group IV (n=108): CAN-positive, ≥2 MS components. LV geometry type, as well as LV systolic and diastolic function, was assessed according to the standard criteria. Results. LV concentric hypertrophy (LVCH) was the most prevalent type of LV geometry in CAN-positive vs. CAN-negative patients (62,2% vs. 20,0%, respectively; p=0,02). The highest LVCH prevalence (63,9%) was registered in participants with CAN and ≥2 MS components. Over 50% of the patients with 0–1 MS component and two-thirds of the patients with ≥2 MS components had disturbed LV diastolic function. In the former, CAN presence did not affect the prevalence of diastolic dysfunction, while in the latter, diastolic dysfunction was significantly more prevalent among CAN-positive individuals (90,7%, compared to 56,2% in CAN-negative patients with ≥2 MS components; p=0,001). Conclusion. In DM-2 patients, CAN was associated with LVCH andLV diastolic dysfunction. This association strengthened, as the number of MS components increased.https://cardiovascular.elpub.ru/jour/article/view/2067type 2 diabetes mellituscardiac autonomic neuropathymetabolic syndromeechocardiography
spellingShingle E. Yu. Lunina
I. S. Petrukhin
Changes in left ventricular structure and function in Type 2 diabetic patients, depending on the presence of cardiac autonomic neuropathy and metabolic syndrome components
Кардиоваскулярная терапия и профилактика
type 2 diabetes mellitus
cardiac autonomic neuropathy
metabolic syndrome
echocardiography
title Changes in left ventricular structure and function in Type 2 diabetic patients, depending on the presence of cardiac autonomic neuropathy and metabolic syndrome components
title_full Changes in left ventricular structure and function in Type 2 diabetic patients, depending on the presence of cardiac autonomic neuropathy and metabolic syndrome components
title_fullStr Changes in left ventricular structure and function in Type 2 diabetic patients, depending on the presence of cardiac autonomic neuropathy and metabolic syndrome components
title_full_unstemmed Changes in left ventricular structure and function in Type 2 diabetic patients, depending on the presence of cardiac autonomic neuropathy and metabolic syndrome components
title_short Changes in left ventricular structure and function in Type 2 diabetic patients, depending on the presence of cardiac autonomic neuropathy and metabolic syndrome components
title_sort changes in left ventricular structure and function in type 2 diabetic patients depending on the presence of cardiac autonomic neuropathy and metabolic syndrome components
topic type 2 diabetes mellitus
cardiac autonomic neuropathy
metabolic syndrome
echocardiography
url https://cardiovascular.elpub.ru/jour/article/view/2067
work_keys_str_mv AT eyulunina changesinleftventricularstructureandfunctionintype2diabeticpatientsdependingonthepresenceofcardiacautonomicneuropathyandmetabolicsyndromecomponents
AT ispetrukhin changesinleftventricularstructureandfunctionintype2diabeticpatientsdependingonthepresenceofcardiacautonomicneuropathyandmetabolicsyndromecomponents